This inventor holds 1 USPTO granted patent and 7 published patent applications and 1 EPO patent. Top assignee: Targazyme, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Lynnet Koh: Innovator in Cell Therapy
Introduction
Lynnet Koh is a prominent inventor based in Carlsbad, CA (US). She has made significant contributions to the field of cell therapy, particularly through her innovative approaches to enhancing treatment efficacy.
Latest Patents
Lynnet holds a patent titled "Augmentation of cell therapy efficacy including treatment with alpha 1,3 fucosyltransferase." This patent discloses methods, compositions of matter, and kits that are useful for augmenting cells by modifying cellular membrane properties following ex vivo treatment. She has 1 patent to her name, showcasing her dedication to advancing medical science.
Career Highlights
Lynnet is currently employed at Targazyme, Inc., where she continues to develop groundbreaking therapies. Her work focuses on improving the effectiveness of cell-based treatments, which has the potential to revolutionize patient care.
Collaborations
Lynnet collaborates with Leonard Miller, contributing to the innovative environment at Targazyme, Inc. Their partnership exemplifies the importance of teamwork in driving scientific advancements.
Conclusion
Lynnet Koh is a trailblazer in the field of cell therapy, with her innovative patent and work at Targazyme, Inc. Her contributions are paving the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile